Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3

Deregulated activation of oncogenic transcription factors such as signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in proliferation and survival of hepatocellular carcinoma (HCC). Thus, agents which can inhibit STAT3 activation may have an enormous potential for treatm...

Full description

Bibliographic Details
Main Authors: Dai, X., Ahn, K., Kim, C., Siveen, K., Ong, T., Shanmugam, M., Li, F., Shi, J., Kumar, Alan Prem, Wang, L., Goh, B., Magae, J., Hui, K., Sethi, G.
Format: Journal Article
Published: Elsevier 2015
Online Access:http://hdl.handle.net/20.500.11937/50847
_version_ 1848758550251175936
author Dai, X.
Ahn, K.
Kim, C.
Siveen, K.
Ong, T.
Shanmugam, M.
Li, F.
Shi, J.
Kumar, Alan Prem
Wang, L.
Goh, B.
Magae, J.
Hui, K.
Sethi, G.
author_facet Dai, X.
Ahn, K.
Kim, C.
Siveen, K.
Ong, T.
Shanmugam, M.
Li, F.
Shi, J.
Kumar, Alan Prem
Wang, L.
Goh, B.
Magae, J.
Hui, K.
Sethi, G.
author_sort Dai, X.
building Curtin Institutional Repository
collection Online Access
description Deregulated activation of oncogenic transcription factors such as signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in proliferation and survival of hepatocellular carcinoma (HCC). Thus, agents which can inhibit STAT3 activation may have an enormous potential for treatment of HCC patients. Hence, in the present report, we investigated the effect of ascochlorin (ASC), an isoprenoid antibiotic on STAT3 activation cascade in various HCC cell lines and orthotopic mouse model. We observed that ASC could substantially inhibit both constitutive and IL-6/EGF inducible STAT3 activation as well as reduce its DNA binding ability. ASC increased the expression of protein inhibitor of activated STAT3 (PIAS3) which could bind to STAT3 DNA binding domain and thereby down-regulate STAT3 activation. Deletion of PIAS3 gene by siRNA abolished the ability of ASC to inhibit STAT3 activation and induce apoptosis in HCC cells. ASC also modulated the expression of diverse STAT3-regulated oncogenic gene products. Finally, when administered intraperitoneally, ASC also inhibited tumor growth in an orthotopic HCC mouse model and reduced STAT3 activation in tumor tissues. Overall our results indicate that ASC mediates its anti-tumor effects predominantly through the suppression of STAT3 signaling cascade, and can form the basis of novel therapy for HCC patients.
first_indexed 2025-11-14T09:45:46Z
format Journal Article
id curtin-20.500.11937-50847
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:45:46Z
publishDate 2015
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-508472017-09-13T15:49:25Z Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3 Dai, X. Ahn, K. Kim, C. Siveen, K. Ong, T. Shanmugam, M. Li, F. Shi, J. Kumar, Alan Prem Wang, L. Goh, B. Magae, J. Hui, K. Sethi, G. Deregulated activation of oncogenic transcription factors such as signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in proliferation and survival of hepatocellular carcinoma (HCC). Thus, agents which can inhibit STAT3 activation may have an enormous potential for treatment of HCC patients. Hence, in the present report, we investigated the effect of ascochlorin (ASC), an isoprenoid antibiotic on STAT3 activation cascade in various HCC cell lines and orthotopic mouse model. We observed that ASC could substantially inhibit both constitutive and IL-6/EGF inducible STAT3 activation as well as reduce its DNA binding ability. ASC increased the expression of protein inhibitor of activated STAT3 (PIAS3) which could bind to STAT3 DNA binding domain and thereby down-regulate STAT3 activation. Deletion of PIAS3 gene by siRNA abolished the ability of ASC to inhibit STAT3 activation and induce apoptosis in HCC cells. ASC also modulated the expression of diverse STAT3-regulated oncogenic gene products. Finally, when administered intraperitoneally, ASC also inhibited tumor growth in an orthotopic HCC mouse model and reduced STAT3 activation in tumor tissues. Overall our results indicate that ASC mediates its anti-tumor effects predominantly through the suppression of STAT3 signaling cascade, and can form the basis of novel therapy for HCC patients. 2015 Journal Article http://hdl.handle.net/20.500.11937/50847 10.1016/j.molonc.2014.12.008 Elsevier unknown
spellingShingle Dai, X.
Ahn, K.
Kim, C.
Siveen, K.
Ong, T.
Shanmugam, M.
Li, F.
Shi, J.
Kumar, Alan Prem
Wang, L.
Goh, B.
Magae, J.
Hui, K.
Sethi, G.
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title_full Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title_fullStr Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title_full_unstemmed Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title_short Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
title_sort ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting stat3 signaling cascade through the induction of pias3
url http://hdl.handle.net/20.500.11937/50847